Hyperbaric Oxygen Therapy HBOT

Hyperbaric Oxygen Therapy HBOT Market Outlook

The global Hyperbaric Oxygen Therapy (HBOT) market is projected to reach USD 4.3 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of approximately 7.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic wounds and the rising awareness regarding the benefits of HBOT in wound healing and other medical applications. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, and advancements in hyperbaric chamber technology are anticipated to further stimulate market growth. The rising incidence of conditions such as decompression sickness, carbon monoxide poisoning, and the growing geriatric population are also expected to contribute significantly to the market’s expansion. Moreover, the increasing integration of HBOT in the treatment protocols of various medical conditions is poised to enhance its adoption globally.

Growth Factor of the Market

The growth of the Hyperbaric Oxygen Therapy (HBOT) market is primarily driven by the increasing recognition of its therapeutic benefits across a spectrum of medical conditions. With the rise in chronic diseases, particularly diabetes, which often leads to complications such as non-healing wounds, the demand for advanced treatment options like HBOT is escalating. Furthermore, advancements in medical technology have enhanced the efficacy and safety of hyperbaric treatments, making them more attractive to healthcare practitioners and patients alike. The support of regulatory bodies, such as the FDA, in approving HBOT for various indications also plays a critical role in boosting market acceptance and utilization. Additionally, ongoing research and development activities aimed at exploring new applications of HBOT are likely to expand the market further, as they reveal additional therapeutic benefits that can be harnessed through this treatment modality.

Key Highlights of the Market

• Significant growth driven by increasing prevalence of diabetic foot ulcers and chronic wounds.
• Technological advancements improving the efficacy and safety of HBOT treatments.
• Growing awareness among healthcare professionals and patients regarding the benefits of HBOT.
• Regulatory approval of HBOT for a broader range of medical conditions.
• Emerging markets in Asia Pacific expected to witness the fastest growth rate during the forecast period.

By Application

Wound Healing:

Wound healing is a significant application segment within the Hyperbaric Oxygen Therapy (HBOT) market, as the therapy has shown remarkable efficacy in promoting the healing of chronic wounds and ulcers. The high oxygen concentration delivered during HBOT enhances oxygen supply to hypoxic tissues, stimulating angiogenesis and facilitating the healing process. This has made HBOT an essential treatment modality in managing diabetic foot ulcers and other non-healing wounds. The increasing incidence of chronic wounds, driven by factors such as obesity, diabetes, and an aging population, is expected to propel growth in this application segment significantly in the upcoming years.

Decompression Sickness:

Decompression sickness, often associated with scuba diving, is another critical application segment for HBOT. The therapy is the primary treatment for this condition, where divers experience nitrogen bubbles forming in their bloodstream upon rapid ascent. HBOT effectively reduces these bubbles and restores normal gas exchange, preventing serious neurological complications. The growing popularity of recreational diving activities, along with increased awareness of safety protocols, is likely to sustain the demand for HBOT in this application. Furthermore, the rising number of diving-related incidents will continue to highlight the importance of HBOT in emergency and critical care settings.

Carbon Monoxide Poisoning:

Carbon monoxide poisoning represents a vital segment in the HBOT market, given its potential to cause life-threatening health issues. HBOT serves as an effective treatment option by displacing carbon monoxide from hemoglobin, thereby restoring oxygen delivery to tissues. The increasing incidence of carbon monoxide poisoning due to improper heating systems and vehicle emissions is driving demand for HBOT as an urgent care solution. Public health campaigns aimed at raising awareness about the dangers of carbon monoxide exposure further augment the need for effective treatments, ensuring that HBOT remains a critical intervention in such cases.

Gas Embolism:

Gas embolism, which can occur due to surgical procedures or diving accidents, is another significant application for HBOT. The therapy helps to reduce the size of gas bubbles in the bloodstream, preventing serious complications such as ischemia and organ dysfunction. With rising awareness and advancements in surgical techniques that reduce complications, the demand for HBOT in this area is expected to witness solid growth. Increased focus on patient safety and recovery in healthcare settings will further enhance the adoption of HBOT for gas embolism treatment.

Others:

Under the 'Others' category, various additional applications of HBOT are emerging, including treatment for thermal burns, osteomyelitis, and certain infections. These applications are gaining traction due to the versatility of HBOT, which can enhance recovery and improve outcomes for a range of medical conditions. The expanding body of clinical evidence supporting off-label uses of HBOT will likely contribute to its growth across diverse medical scenarios. As healthcare providers continue to explore innovative treatment options, the 'Others' segment is expected to see notable advancements and increased acceptance within clinical practices.

By End User

Hospitals:

Hospitals are the primary end users of Hyperbaric Oxygen Therapy (HBOT), as they are equipped with the necessary infrastructure and skilled professionals to administer this advanced treatment. The integration of HBOT into hospital settings is facilitated by the increasing prevalence of conditions that require hyperbaric treatment, such as chronic wounds and decompression sickness. Hospitals also benefit from access to advanced hyperbaric chambers, enabling them to provide effective and safe treatment modalities. The growing focus on patient-centered care and the rising adoption of multi-disciplinary approaches in hospitals further support the demand for HBOT in these healthcare facilities.

Clinics:

Clinics have emerged as a significant end user for HBOT, driven by the growing trend of outpatient care and the need for accessible treatment options for chronic conditions. Many clinics are now equipped with hyperbaric chambers, allowing them to offer HBOT as part of their therapeutic services. The convenience of receiving treatment in a clinical setting, along with the ability to manage patient flow efficiently, makes clinics an attractive option for both patients and providers. Furthermore, the increasing collaboration between clinics and hospitals is enabling seamless patient referrals, thereby enhancing the overall utilization of HBOT.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly incorporating Hyperbaric Oxygen Therapy (HBOT) into their treatment protocols, particularly for patients with complex wounds and surgical complications. The ability to provide timely and effective care in a cost-effective manner positions ASCs as key players in the HBOT market. The focus on minimizing hospital stay durations and enhancing patient recovery experiences drives the demand for HBOT in ASCs. Additionally, as surgical technologies advance and surgical procedures become less invasive, the integration of supportive therapies like HBOT is expected to grow in importance.

Rehabilitation Centers:

Rehabilitation centers represent a growing end user segment for HBOT, particularly for patients recovering from injuries, surgeries, or chronic conditions. The therapy aids in enhancing tissue oxygenation and promoting healing, which is crucial for effective rehabilitation. Facilities that focus on providing comprehensive care and rehabilitation services are increasingly recognizing the value of HBOT in improving patient outcomes. As the understanding of holistic recovery approaches continues to evolve, the incorporation of HBOT into rehabilitation practices is anticipated to become more prevalent, driving growth in this segment.

Others:

The 'Others' segment encompasses various end users, including specialized clinics, sports medicine facilities, and wellness centers that offer HBOT for therapeutic or preventative purposes. This diverse application underscores the versatility of HBOT beyond traditional medical settings, catering to patients seeking alternative treatments for injury recovery and overall wellness. The rising consumer interest in health and wellness, along with an increasing focus on integrative medicine approaches, is likely to fuel the growth of HBOT services in non-traditional healthcare environments, expanding its footprint in the market.

By Indication

Diabetic Foot Ulcers:

Diabetic foot ulcers are among the most common indications for Hyperbaric Oxygen Therapy (HBOT), as these chronic wounds are notoriously difficult to heal and often lead to severe complications, including amputations. The high oxygen levels provided during HBOT significantly enhance oxygen delivery to compromised tissues, thereby promoting healing and recovery. The prevalence of diabetes continues to rise globally, leading to an increasing number of patients suffering from foot ulcers, which in turn drives the demand for HBOT as an effective treatment option. The focus on improving patient outcomes and reducing healthcare costs associated with diabetes-related complications further solidifies the role of HBOT in managing diabetic foot ulcers.

Non-healing Wounds:

Non-healing wounds represent another critical indication for HBOT, as the therapy has demonstrated remarkable success in promoting tissue repair and healing. Chronic wounds, including venous ulcers and pressure injuries, often require advanced treatment modalities to address underlying issues such as poor blood circulation and infection. HBOT enhances the healing process by stimulating collagen production and improving tissue oxygenation. The rising incidence of non-healing wounds, particularly among the elderly and those with comorbidities, continues to emphasize the importance of HBOT in wound management strategies, thereby contributing to the growth of this indication segment.

Radiation Injury:

Radiation injury is an important indication for HBOT, particularly in patients undergoing treatment for cancer. Radiation therapy can lead to tissue damage and delayed healing, making HBOT a valuable adjunct therapy in managing these complications. The high oxygen levels delivered during HBOT help mitigate the effects of radiation on healthy tissues, promoting healing and recovery. As cancer treatments continue to advance and evolve, the integration of supportive therapies like HBOT is expected to become more common, driving the demand for HBOT in treating radiation injuries and enhancing the overall quality of care for cancer patients.

Thermal Burns:

HBOT is increasingly recognized for its effectiveness in the treatment of thermal burns, particularly in cases of deep second and third-degree burns. The therapy helps to reduce edema, promote healing, and minimize the risk of infections by improving oxygen supply to damaged tissues. The rising incidence of burn injuries, coupled with the need for advanced treatment protocols to enhance recovery, supports the demand for HBOT in burn care. As healthcare providers focus on improving patient outcomes and recovery times, the application of HBOT in managing thermal burns is expected to expand significantly.

Others:

The 'Others' category includes various indications such as osteomyelitis, crush injuries, and certain types of infections where HBOT can provide therapeutic benefits. This segment is gaining attention as research continues to unveil the diverse applications of HBOT in treating a range of medical conditions. The expanding body of clinical evidence supporting the efficacy of HBOT for various indications is likely to drive growth in this segment, as healthcare professionals explore innovative treatment options for complex medical challenges. As awareness of these additional indications increases, the demand for HBOT is expected to rise across different therapeutic areas.

By Chamber Type

Monoplace HBOT Chambers:

Monoplace HBOT chambers represent a popular chamber type in the market, designed to accommodate a single patient at a time. This model allows for personalized treatment, as patients are isolated in a controlled environment where they can receive hyperbaric oxygen therapy without external distractions. The ease of use and efficient space utilization make monoplace chambers a preferred choice for clinics and hospitals that aim to offer HBOT services. As the demand for outpatient care increases, the adoption of monoplace chambers is anticipated to grow, facilitating broader access to therapeutic oxygen treatments.

Multiplace HBOT Chambers:

Multiplace HBOT chambers are designed to treat multiple patients simultaneously, making them an efficient option for facilities with higher patient volumes. These chambers can accommodate several patients, along with medical personnel, in a single session, allowing for a more efficient treatment process. The versatility of multiplace chambers enables healthcare facilities to treat various conditions at once, optimizing resource utilization. As healthcare providers strive for enhanced patient care and operational efficiency, the adoption of multiplace chambers is expected to rise within the HBOT market.

Topical HBOT Chambers:

Topical HBOT chambers are relatively novel and are increasingly being explored for localized treatment applications, particularly for chronic wounds and superficial injuries. These chambers allow for targeted delivery of oxygen to specific body parts, providing an effective alternative for patients who may not require full-body treatment. The rise in interest for less invasive and more manageable treatment options supports the growing adoption of topical HBOT chambers in various clinical settings. As clinical evidence continues to support the benefits of localized oxygen therapy, this segment is likely to witness significant growth.

By Region

North America:

North America holds a significant share of the Hyperbaric Oxygen Therapy (HBOT) market, accounting for approximately 45% of the global revenue. The region's dominance can be attributed to the well-established healthcare infrastructure, high prevalence of chronic diseases, and increasing awareness about the therapeutic benefits of HBOT. Additionally, the presence of advanced medical technology and a growing number of hyperbaric chambers in hospitals and clinics are further propelling market growth in North America. The projected CAGR for the North American HBOT market during the forecast period is approximately 7.0%, reflecting the continued emphasis on improving patient care and outcomes.

Europe:

Europe is another major region in the HBOT market, contributing around 30% to the overall market share. The growth in this region is driven by increasing investments in healthcare infrastructure and rising awareness among healthcare professionals about the benefits of HBOT. Countries such as Germany, the UK, and France are leading contributors to the market, supported by favorable reimbursement policies and growing collaborations between healthcare providers. The European market is expected to experience a CAGR of approximately 6.5% over the forecast period, fueled by ongoing research and the expansion of HBOT applications in clinical practice.

Opportunities

The Hyperbaric Oxygen Therapy (HBOT) market presents numerous opportunities for growth, particularly in emerging economies where healthcare infrastructure is expanding. As countries in Asia Pacific and Latin America continue to develop their healthcare systems, the demand for advanced treatment modalities such as HBOT is expected to rise significantly. The increasing prevalence of chronic diseases, coupled with growing awareness of the benefits of HBOT, creates a favorable environment for market expansion. Furthermore, collaborations between public and private sectors to enhance healthcare accessibility will open avenues for HBOT adoption in these regions, providing a substantial opportunity for growth in the coming years.

Additionally, ongoing research and development activities aimed at exploring new applications of HBOT offer significant opportunities for market players. As clinical studies continue to unveil the potential benefits of HBOT for various indications, healthcare providers are likely to integrate these findings into their treatment protocols. The growing interest in regenerative medicine and novel therapeutic approaches will further drive demand for HBOT as an adjunct therapy. By targeting unmet medical needs and expanding the range of conditions that can be treated with HBOT, companies can position themselves advantageously within the evolving market landscape.

Threats

While the Hyperbaric Oxygen Therapy (HBOT) market exhibits positive growth prospects, it also faces potential threats that could hinder progress. One significant threat is the increasing incidence of regulatory challenges, as healthcare practices and technologies undergo constant scrutiny by governing bodies. As new evidence emerges regarding the safety and efficacy of HBOT for various indications, there may be adjustments in regulatory approvals that could impact market dynamics. Additionally, competition from alternative therapies, including advanced wound care products and other treatment modalities, may pose a challenge to the adoption of HBOT as a primary treatment option. In order to maintain market position, stakeholders need to continuously innovate and demonstrate the value of HBOT in comparison to other therapies.

Moreover, the high costs associated with setting up and maintaining hyperbaric chambers may deter smaller healthcare providers from incorporating HBOT into their offerings. This could lead to a concentration of services within larger hospitals and specialized clinics, limiting access for patients who may benefit from HBOT in less urbanized areas. Addressing these barriers will be essential for ensuring equitable access to HBOT and realizing the therapy’s full potential across diverse patient populations.

Competitor Outlook

• OxyHealth LLC
• Gambro Healthcare
• Sechrist Industries, Inc.
• Hyperbaric Technologies, Inc.
• Broncus Medical
• Merits Health Products
• Environmental Tectonics Corporation
• Haux-Life-Support GmbH
• US Hyperbarics Inc.
• Hyperbaric Medical Solutions
• AHA Hyperbarics
• W.E. Anderson, Inc.
• APC Health
• Hiperbaric S.L.
• Thermal Dynamics Inc.

The competitive landscape of the Hyperbaric Oxygen Therapy (HBOT) market is characterized by a diverse range of players, including manufacturers of hyperbaric chambers, healthcare providers, and specialized clinics. Companies are continuously innovating to enhance the efficiency and safety of HBOT, with a focus on advancing chamber technology and improving patient experiences. Market players are also engaging in strategic partnerships and collaborations to expand their geographic reach and service offerings. This competitive environment encourages the development of diverse treatment protocols and the exploration of new applications for HBOT, positioning the market for sustained growth.

Among the key players in the HBOT market, OxyHealth LLC stands out for its commitment to providing innovative hyperbaric chamber solutions tailored to various medical applications. Their advanced monoplace and multiplace chambers are designed to maximize patient comfort while optimizing therapeutic efficacy. Additionally, Sechrist Industries, Inc. has established itself as a leader in manufacturing hyperbaric chambers and is known for its focus on quality and safety standards in the production process. Environmental Tectonics Corporation is another major player that offers a wide range of hyperbaric medical products and services, emphasizing research and development to meet evolving patient needs.

Haux-Life-Support GmbH has garnered attention for its state-of-the-art technology in hyperbaric systems, catering to hospitals and clinics that prioritize advanced medical care. The company’s products are recognized for their reliability and efficiency, making them a preferred choice among healthcare professionals. In the context of global expansion, companies such as Hyperbaric Medical Solutions and AHA Hyperbarics are actively pursuing opportunities in emerging markets, capitalizing on the growing demand for HBOT in regions with limited access to advanced healthcare options. Overall, the competitive landscape reflects a dynamic market poised for further development in response to evolving healthcare needs.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 APC Health
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 OxyHealth LLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 AHA Hyperbarics
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Broncus Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hiperbaric S.L.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Gambro Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 US Hyperbarics Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 W.E. Anderson, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Thermal Dynamics Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Haux-Life-Support GmbH
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Merits Health Products
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Sechrist Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hyperbaric Medical Solutions
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hyperbaric Technologies, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Environmental Tectonics Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Hyperbaric Oxygen Therapy HBOT Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Rehabilitation Centers
    • 6.1.5 Others
  • 6.2 Hyperbaric Oxygen Therapy HBOT Market, By Indication
    • 6.2.1 Diabetic Foot Ulcers
    • 6.2.2 Non-healing Wounds
    • 6.2.3 Radiation Injury
    • 6.2.4 Thermal Burns
    • 6.2.5 Others
  • 6.3 Hyperbaric Oxygen Therapy HBOT Market, By Application
    • 6.3.1 Wound Healing
    • 6.3.2 Decompression Sickness
    • 6.3.3 Carbon Monoxide Poisoning
    • 6.3.4 Gas Embolism
    • 6.3.5 Others
  • 6.4 Hyperbaric Oxygen Therapy HBOT Market, By Chamber Type
    • 6.4.1 Monoplace HBOT Chambers
    • 6.4.2 Multiplace HBOT Chambers
    • 6.4.3 Topical HBOT Chambers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Hyperbaric Oxygen Therapy HBOT Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Hyperbaric Oxygen Therapy HBOT market is categorized based on

By Application

• Wound Healing
• Decompression Sickness
• Carbon Monoxide Poisoning
• Gas Embolism
• Others

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Rehabilitation Centers
• Others

By Indication

• Diabetic Foot Ulcers
• Non-healing Wounds
• Radiation Injury
• Thermal Burns
• Others

By Chamber Type

• Monoplace HBOT Chambers
• Multiplace HBOT Chambers
• Topical HBOT Chambers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• OxyHealth LLC
• Gambro Healthcare
• Sechrist Industries, Inc.
• Hyperbaric Technologies, Inc.
• Broncus Medical
• Merits Health Products
• Environmental Tectonics Corporation
• Haux-Life-Support GmbH
• US Hyperbarics Inc.
• Hyperbaric Medical Solutions
• AHA Hyperbarics
• W.E. Anderson, Inc.
• APC Health
• Hiperbaric S.L.
• Thermal Dynamics Inc.